Technology News and Research

RSS

Vinformatix receives ONC-ATCB certification for MedSonic EMR solution

Vinformatix announced today that after integrating the Healthwise Patient Education EMR Module and its patient-friendly content, the MedSonic EMR has earned certification from InfoGard Laboratories, an authorized Office of the National Coordinator for Health Information Technology—Authorized Testing and Certification Body.

19 May 2011

A new gene expression analysis technique on a single molecule sequencer

A new gene expression technique adapted for single molecule sequencing has enabled researchers at the RIKEN Omics Science Center (OSC) to accurately and quantitatively measure gene expression levels using only 100 nanograms of total RNA. The technique, which pairs RIKEN's Cap Analysis of Gene Expression (CAGE) protocol with the Helicos(R) Genetic Analysis System developed by Helicos BioSciences Corporation, opens the door to the detailed analysis of gene expression networks and rare cell populations. In recent years, next-generation DNA sequencers have produced an increasingly detailed picture of how genes are expressed at the molecular level. The transcriptional output of these genes - the RNA copies produced from DNA - has revealed a richness of complexity in transcript structure and function, providing insights into the molecular-level properties of cancers and other diseases.

19 May 2011

Inspector General: Push for EMRs overlooks security issues

The Office of the Inspector General found "a lack of general [information technology] security controls during prior audits at Medicare contractors, State Medicaid agencies, and hospitals."

19 May 2011

Serpin-2 molecule may be a perfect target for preventing mosquito's immunity

Mosquitoes are becoming more resistant to current pesticides. That's troubling to Kansas State University biologist Kristin Michel, as it means malaria and other mosquito-borne diseases will continue spreading. A recent grant from the National Institutes of Health may change all that.

18 May 2011

Momentive Performance Materials collaborates with SSF to develop combination products

Momentive Performance Materials Inc. today announced a collaboration initiative with Specialty Silicone Fabricators (SSF) to develop combination products for medical devices manufacturers.

18 May 2011

InvoTek introduces new Safe Laser System for persons with limited movement

InvoTek, Inc., a research and development company in Alma, Arkansas, has launched a new product using safe laser technology that enables a person with limited movement to write, communicate, and control their environment. The product will be unveiled at the Abilities Expo 2011 in Newark, New Jersey on Friday, May 20, 2011.

18 May 2011

U-Systems introduces RCC Transducer Technology for somo•v Automated Breast Ultrasound system

U-Systems, the leader in automated breast ultrasound, launched a revolutionary new transducer technology designed to deliver unparalleled imaging performance and patient comfort. Reverse-Curve Crystal™ (RCC) Transducer Technology was designed and optimized for use with the U-Systems' somo•v® Automated Breast Ultrasound (ABUS) system.

18 May 2011

MDxHealth reduces first quarter net loss by 17%

MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, today issued its business update for the quarter ended March 31, 2011.

18 May 2011

Cameron Health announces completion of $107 million equity financing round

Cameron Health, Inc., developer of the world's only completely subcutaneous implantable defibrillator, announced today that it has completed a $107 million equity financing round led by Alloy Ventures and Delphi Ventures.

18 May 2011

Affymetrix launches new menu of multiple genomic microarray tools

Affymetrix, Inc. today announced the availability of multiple genomic microarray tools that will further enable scientists in the applied research field.

18 May 2011

Synergy expands GC-C agonist technology to lower cholesterol

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, announced today that it has successfully completed preclinical in vitro research demonstrating the inhibition of bile acid uptake by GC-C agonists and that it plans to commence animal studies shortly. Synergy believes this is the first time that GC-C agonists have been shown to potentially lower cholesterol.

18 May 2011

Improved tissue grafts promote vascular growth in wound sites

Victims of third-degree burns and other traumatic injuries endure pain, disfigurement, invasive surgeries and a long time waiting for skin to grow back. Improved tissue grafts designed by Cornell scientists that promote vascular growth could hasten healing, encourage healthy skin to invade the wounded area and reduce the need for surgeries.

18 May 2011

Clinipace Worldwide announces acquisition of PFC

Clinipace Worldwide, a global digital clinical research organization, and Swiss-based PFC Pharma Focus today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries.

18 May 2011

CitiusTech receives ONC-ATCB certification for BI-Clinical 10.3 EHR Module

CitiusTech announced today that BI-Clinical Framework 10.3 is 2011/2012 compliant and was certified as an EHR Module on May 12, 2011 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable Eligible Hospital certification criteria adopted by the Secretary of Health and Human Services.

18 May 2011

Scientists detect potentially toxic flame retardants in common baby products

Scientists are reporting detection of potentially toxic flame retardants in car seats, bassinet mattresses, nursing pillows, high chairs, strollers, and other products that contain polyurethane foam and are designed for newborns, infants and toddlers.

18 May 2011

UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology

The University of Washington Center for Commercialization and Pharmigene, a leader in advancing personalized medicine and reducing severe adverse reactions to drugs through genetic-based diagnostic solutions, today announced the execution of a licensing agreement between the parties.

18 May 2011

Unigene to present proprietary recombinant production, oral peptide drug delivery technology at TIDES Summit

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company will be presenting a poster and an oral presentation on its propriety recombinant production and oral peptide drug delivery technology during the upcoming 2011 TIDES: Oligonucleotide and Peptide Research, Technology and Product Development Summit being held at the Hynes Convention Center and Sheraton Boston Hotel in Boston, MA from May 22 - 25, 2011.

18 May 2011

Neurochemical basis for sleep deprivation's effects on memory

From high-school students to surgeons, anyone who has pulled an all-nighter knows there is a price to be paid the next day: trouble focusing, a fuzzy memory and other cognitive impairments. Now, researchers at Penn have found the part of the brain and the neurochemical basis for sleep deprivation's effects on memory.

18 May 2011

The Incubation Factory, UMDNJ and NJIT partner to commercialize personal tonometer for glaucoma

NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, PhD, and Robert Fechtner, MD, director of the glaucoma division at UMDNJ.

18 May 2011

Study offers new understanding of cell signaling networks tied to diabetes and cancer

Researchers at the University of Texas Medical Branch at Galveston and the University of California-San Diego School of Medicine have published a study that offers a new understanding of a protein critical to physiological processes involved in major diseases such as diabetes and cancer. This work could help scientists design drugs to battle these disorders.

18 May 2011